Lexicon Pharmaceuticals Inc [NASDAQ: LXRX] closed the trading session at $13410000.0 on 2025-06-25. ...
HC Wainwright restated a "buy" rating and issued a $4.00 price target on shares of Lexicon Pharmaceu...
Lexicon Pharmaceuticals (LXRX) will present clinical data at the 85th ADA Scientific Sessions on Jun...
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Free Report) has been assigned an average recommend...
THE WOODLANDS, Texas, June 18, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) ...